Bicameral Letter Issued to OSTP Director on Establishing Biosecurity Guardrails in DNA Research

April 1, 2024

United StatesU.S. Congress

Summary

On April 1, 2024, Reps. Julia Brownley (D-CA), Dan Crenshaw (R-TX), Neal P. Dunn (R-FL), Bill Foster (D-IL), Andy Harris (R-MD), Sara Jacobs (D-CA), Rich McCormick (R-GA), August Pfluger (R-TX), Haley Stevens (D-MI), alongside Sen. Ed Markey (D-MA), sent a letter to Office of Science and Technology Policy (OSTP) Director Arati Prabhakar, in which they urged her to issue the framework around mitigating risks associated with synthetic nucleic acids, emphasizing safety and innovation in gene synthesis practices. The letter calls on OSTP to include funding for infrastructure to facilitate screening, the implementation of biannual confidential stress-testing reporting, and international engagement to harmonize gene synthesis screening protocols.

Share This Page

Additional Information

Questions?

Email contacts@akingump.com for questions or additional insights.

Giving you full access to the latest in AI across regulatory developments, legal and policy issues, and industry news.

Akin Intelligence Newsletter

Subscribe to Akin Intelligence, our monthly newsletter recapping the latest in AI and its impact on various sectors. 

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.